Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Resources
Scientific Publications
Jan 10, 2025
Comparing two-sample log-linear exposure estimation with Bayesian model-informed precision dosing of tobramycin in adult patients with cystic fibrosis
White Papers
May 29, 2024
Case Study: Pre-/Post-Implementation; Can Bayesian MIPD enhance target attainment and clinical outcomes for patients receiving vancomycin?
Scientific Publications
Nov 29, 2023
Thomson model results in higher vancomycin AUC target attainment rates in non-morbidly obese adults
Scientific Publications
Mar 8, 2023
Evaluating and Improving Neonatal Gentamicin Pharmacokinetic Models Using Aggregated Routine Clinical Care Data
